期刊文献+

胃癌患者外周血骨桥蛋白的检测 被引量:3

Detection of Osteopontin in Plasma of Patients with Gastric Cancer
暂未订购
导出
摘要 目的:探讨骨桥蛋白(OPN)作为胃癌肿瘤标志物的价值,并与CEA、CA19-9进行比较。方法:应用酶联免疫吸附试验法(ELISA)检测66例胃癌患者的外周血(OPN)、CEA、CA19-9的浓度,结合临床特征进行分析。结果:胃癌患者OPN、CEA、CA19-9检测的敏感性分别为78.8%、34.8%、42.4%,特异性分别为95.0%、90.0%、80.0%。三种标志物联合检测,其敏感性为87.8%。OPN、CEA、CA19-9浓度与胃癌临床分期、最大直径、淋巴结转移程度及有无远处转移有关,手术前后三种标志物浓度具有显著性差异。结论:骨桥蛋白是胃癌的一种较理想的肿瘤标志物,三者联合检测能够用于胃癌的诊断和预后评估,监测病情的进展。 Objective:To evaluate the significance of osteopontin as a tumor marker and compare with carcinoembryonic antigen and carbohydrate antigen19-9in gastric cancer.Meth-ods :Plasma level of osteopontin,carcinoembryonic antigen and carbohydrate antigen19-9were detected in66patients with gastric cancer by ELISA method.The relationship between the level of osteopontin,carcinoembryonic antigen,carbohydrate antigen19-9and the clinical features of gas-tric cancer were analyzed.Results:The sensitivity of osteopontin,carcinoembryonic antigen,car-bohydrate antigen19-9was78.8%?34.8%?42.4%and the specifity of the three markers is95%?90%?80%respectively.The sensitivity of combined detection of three markers is87.8%.Levels of osteopontin,carcinoembryonic antigen,carbohydrate antigen19-9were related with TNM stage,maximum diameter,degree of lymphnode metastasis,metastasis in gastric cancer.Pre-and postop-erative levles of the three markers were obviously different.Conclusion:Osteopontin was one of the ideal tumor markers and it could be used in diagnosis,prognois evaluation,monitoring for gastric cancer combined with carcinoembryonic antigen,carbohydrate antigen 19-9.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第12期881-884,共4页 Chinese Journal of Clinical Oncology
关键词 胃癌 外周血 骨桥蛋白 检测 癌胚抗原 CA19-9 Gastric neoplasm Osteopontin Carcinoembryonic antigen Carbohydrate antigen 19-9 Plasma
  • 相关文献

参考文献11

  • 1[1]Saitoh Y, Kuratsu J, Takeshima H, et al. Expression of osteopontin in human glioma. Its correlation with the malignancy.Lab Invest, 1995,72(1):55~63
  • 2[2]Bautista DS, Saad Z, Chambers AF, et al. Quantification of osteopontin in human plasma with an ELISA:basal levels in pre and postmenopausal woman. Clin Biochem, 1996,29(3):231~239
  • 3[3]Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-biding sequence. Proc Natl Acad Sci USA, 1986, 83(12): 8819~8823
  • 4[4]Ross FP, Chappel J, Alvarez JI, et al. Interactions between the Bone Matrix Proteins Osteopontin and Bone Sialoprotein and the Osteoclast Integrinα v β3 Potentiate Bone. J Biol Chem,1993, 268(13):9901~9907
  • 5[5]Denhardt DT, Giachelli CM, Rittling SR. Role of Osteopontin in celluar signaling ang toxicant injury. Annu Rev Pharmacol Toxicol, 2001,41:723~749
  • 6[6]Tuck AB, Malley FP, Singhal H, et al. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch Pathol Lab Med, 1997, 121(6):578~584
  • 7[7]Crawford HC, Matrisian LM, Liaw L. Distinct role of osteopontin in host defense activity and rumor survival during sqamous cell carcinoma progression in Vivo. Cancer Res, 1998,58:5206~5215
  • 8[8]Gaspar MJ, Arribas I, Coca MC, et al. Prognostic value of carcinoembryonic antigen, CA19-9 and CA72-4 in gastric carcinoma. Tumor Biol, 2001,22:318~322
  • 9[9]Yamao T, Kai S, Kazami A, et al. Tumor markers CEA,GA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer. Jpn JClin Oncol, 1999, 29(11):550~555
  • 10[10]Singhal H, Bautista DS, Tonkin KS, et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res, 1997,3(4): 605~611

同被引文献19

  • 1陈益定,郑树,余捷凯,胡汛.血清蛋白质质谱模型在大肠癌诊断中的应用[J].中华肿瘤杂志,2004,26(7):417-420. 被引量:42
  • 2余捷凯,杨美琴,姜铁军,郑树.血清肿瘤标志物优化组合人工神经网络模型在大肠癌诊断中的应用[J].浙江大学学报(医学版),2004,33(5):407-410. 被引量:22
  • 3郜玉峰,李旭,谢琴秀,桂淑玉,汪渊,周青,李家斌,江晓平.骨桥蛋白和CD44v6在肝癌中的表达及意义[J].中华肝脏病杂志,2005,13(3):227-228. 被引量:16
  • 4[1]Dong JT,Lamb PW,Rinker-Schaeffer CW,et al.KAI1,a metastasis suppressor gene for prostate cancer on human chromosome 11pl 1.2.Science,1995,268:884-886.
  • 5[2]Kim JH,Kim B,Cai L,et al.Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes.Nature,2005,434:921-926.
  • 6[3]Guo XZ,Xu JH,Liu MP,et al.KAI1 inhibits anchorage-dependent and -independent pancreatic cancer cell growth.Oncol Rep,2005,14:59-63.
  • 7[4]Bellahcene A,Castronovo V.Increased expression of osteonectin and osteopontin,two bone matrix proteins,in human breast cancer.Am J Pathol,1995,146:95-100.
  • 8[5]Hu Z,Lin D,Yuan J,et al.Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer.Clin Cancer Res,2005,11:4646-4652.
  • 9[6]Tuck AB,O'Malley FP,Singhal H,et al.Osteopontin and p53 expression are associated with tumor progression in a case of synchronous,bilateral,invasive mammary carcinomas.Arch Pathol Lab Med,1997,121:578-584.
  • 10[7]Shimada,Y,Watanabe G,Kawamura J,et al.Clinical significance of osteopontin in esophageal squamous cell carcinoma:comparison with common tumor markers.Oncology,2005,68:285-292.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部